Frequency of unexpected antibody and consideration during transfusion.

Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea.
Korean journal of anesthesiology 05/2012; 62(5):412-7. DOI: 10.4097/kjae.2012.62.5.412
Source: PubMed

ABSTRACT In this retrospective study, we measured the frequency of unexpected antibodies in the blood. Specific considerations for preoperative preparations were kept in mind for the patients undergoing surgery positive for these antibodies.
After reviewing the results of antibody screening tests lasted for 2 years, the frequency of unexpected antibodies was determined. Surgical patients who were positive for unexpected antibodies were selected and divided into two groups based on their potential need for an intra-operative transfusion (groups with high versus low possibility of transfusion). Blood for the high possibility group was prepared before surgery. For the low possibility group for which preoperative blood preparation was not performed, cases of this group were reviewed whether a blood preparation was delayed or not in case of transfusion.
Among a total 22,463 cases, 340 (1.52%) had positive results for antibody screening tests. Among the 243 patients who were positive for unexpected antibodies, Lewis, Rh, Xga, and mixed antibodies were found in 85, 25, five, and eight cases, respectively. Out of 243 patients, 117 patients, specificities of the unexpected antibodies were not determined and 125 (51.4%) had a history of pregnancy and delivery, and 49 (20.2%) had a history of transfusion. In the low probability group, transfusions were administered for nine patients; transfusion was delayed for two patients due to difficulties with obtaining matched blood.
Patients with unexpected blood antibodies may be at increased risk for delayed transfusion. For rapid transfusion, it might be helpful to keep a record about blood antibodies and introduce a notification system such as medical alert cards. Preoperative blood preparation is needed for timely intraoperative transfusion.

  • false, Korea Medical Publishing Co..
  • [Show abstract] [Hide abstract]
    ABSTRACT: . The antibodies encountered in random collectives of 55,350 recipients, 16,643 pregnant women, and 1,307 mothers of babies with hemolytic disease are listed. Antibody screening was performed in all specimens using the same technique (albumin-antiglobulin test), a limited number of selected sera was investigated also by the auto-analyzer.Different frequencies of the antibodies concerned were found in all groups. Anti-Kell was detected in 10% of all antibodies found in recipients whereas the frequency was less than 0.5% among the antibodies encountered in pregnant women and mothers of babies with hemolytic disease. The relative antigenic potency of the antigens concerned was calculated by taking into account the frequencies of the antibodies and the antigen exposure probability derived from the well-known gene frequencies. Similar to the antibody frequencies, the relative antigenic potencies differ widely from antigen to antigen in the different collectives. By the autoanalyzer technique, it was not possible to detect additional antibodies of presumptive clinical importance. On the other hand, in two exceptional cases, antibodies which caused a hemolytic transfusion reaction were only detected by survival studies.For routine transfusion work, our results lend no support to the alleged advantage of extending antigen determination in donors and recipients.
    Vox Sanguinis 02/1974; 26(6):551-9. · 2.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: For the year 1975, we examined 12,848 blood specimens using the type and screen as well as the crossmatch and detected 283 antibodies in 247 patients. Our screening reagent red blood cells were able to detect 96.11 per cent of these antibodies. If the antigen frequencies corresponding to those antibodies not detectable by our screening reagent red blood cells are taken into consideration. i.e., the incompatibility frequencies, the type and screen can be shown to be 99.99 per cent effective in preventing the transfusion of incompatible blood. Therefore, we believe that the type and screen may be safey substituted for the routine two-unit crossmatch in those operative procedures usually not requiring transfusions. Adoption of this approach would reduce patient charges, provide for more efficient distribution of our limited blood supplies, and allow for more effective utilization of blood-bank technologist time.
    Transfusion 01/1977; 17(2):163-8. · 3.53 Impact Factor


1 Download
Available from